SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Dan O who wrote (7056)8/28/1998 8:20:00 PM
From: Robert K.  Read Replies (2) | Respond to of 17367
 
Great info and footwork guys & gals. If all is to be believed, then this is a false alarm HOWEVER, lets get some verification.>from Ellen<.

ALSO let me say this, I was thinking about takeovers etc.
Hostile and non hostile.
Hostile>probably difficult with poison pill
non-Hostile>Gotta be a high price or a total sell out by management.
Which brings me to how xoma looks as a target.
No patent disputes.
No collaborations or partners to worry about.
Low price.
Big potential.
P3's
Looks like a nice clean target to a suitor.
IMO would have to be non hostile and costly.
Opinions?



To: Dan O who wrote (7056)8/29/1998 4:35:00 PM
From: jackie  Read Replies (1) | Respond to of 17367
 
Dan,

Excellent leg work. Well done. It's nice to see someone take the time to track something down of this nature and then share it with us.

This is the type of posting we need more of. This particular thread contains more than its fair share of good postings and good posters. One only has to spend some time reading through some of the other threads to appreciate what we have here.

Thanks,

Jack Simmons


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News